Use access key #2 to skip to page content.
$8.74 0.09 (1.04%)
10/10/2008 4:00 PM

Tercica, Inc. (TRCA)

CAPS Rating:
*

A biopharmaceutical company focuses on the development and commercialization of new therapeutics for the treatment of short stature and other endocrine disorders.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating TRCA

Add Stock to Watchlist

What the Community Thinks

Total Members

65 Outperforms
12 Underperforms
 

All-Stars

7 Outperforms
4 Underperforms
 

Wall Street

3 Outperforms
0 Underperforms
 

Members bullish on TRCA are also bullish on:

Members bearish on TRCA are also bearish on:

Ticker Tags

Biotechnology (295), Micro Cap (4824)
Suggest a tag

Tercica, Inc. At A Glance

Current Price: $8.74
Last Trade Time: 10/10/2008 4:00 PM
Open: $8.67
Previous Close: $8.65
Daily Range: $8.39 - $8.75
52-Week Range: $3.70 - $8.99
Volume: 448,764
Market Cap: $592.59M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

TRCA VS S&P 500 (SPY)

TRCA 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for TRCA

More Headlines...

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 5  

Show Pitch Replies

Recs

0

 (TRCA)

Avatar bmaple00 (67.35) Submitted: 6/05/08 7:34 PM : Outperform Start Price: $8.78 TRCA Score: 36.51

This one has been on my watch list, I should have rated this one a day earlier.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRCA)

Avatar theonlyslacker (34.27) Submitted: 4/26/07 7:39 AM : Underperform Start Price: $6.74 TRCA Score: -70.47

This stock has had a solid run up with little to no news.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRCA)

Avatar Tradestocky (70.46) Submitted: 3/07/07 2:05 PM : Outperform Start Price: $5.93 TRCA Score: 84.28

Drug companies seem sketchy but if you get on the bandwagon on the way up and get off at the top they leave you feeling pretty high!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRCA)

Avatar fmrick (< 20) Submitted: 2/05/07 5:50 PM : Underperform Start Price: $5.73 TRCA Score: -91.48

If court rules against them in Feb., this goes to zero pretty quick.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRCA)

Avatar GVPenguin (< 20) Submitted: 11/21/06 8:51 PM : Outperform Start Price: $5.25 TRCA Score: 103.64

IGF is just the beginning. Products in the pipeline. Strong management. Give it some time.

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 5  

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCollinsStew 49.48 03/07/07 Outperform NS $6.10+43.28%-36.79%+80.07
TrackLazardCapit < 20 03/07/07 Outperform NS $6.10+43.28%-36.79%+80.07
TrackLehmanBros 73.44 12/01/06 Outperform NS $5.00+74.80%-37.02%+111.82

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners